Gallbladder cancer future or investigational therapies

Gallbladder cancer Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Epidemiology and Demographics
Risk Factors
Screening
Differentiating Gallbladder cancer from other Diseases
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
CT
MRI
Echocardiography and Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Palliative Treatment
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Gallbladder cancer future or investigational therapies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Gallbladder cancer future or investigational therapies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Gallbladder cancer future or investigational therapies
CDC on Gallbladder cancer future or investigational therapies
Gallbladder cancer future or investigational therapies in the news
Blogs on Gallbladder cancer future or investigational therapies
Directions to Hospitals Treating Gallbladder cancer
Risk calculators and risk factors for Gallbladder cancer future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Treatment options under clinical evaluation

Clinical trials are exploring ways of improving local control with radiation therapy combined with radiosensitizer drugs. When possible, such patients are appropriately considered candidates for these studies.